Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 631, pseudogene (RNU6-631P) is a non-coding RNA pseudogene, annotated as a copy related to U6 small nuclear RNA (snRNA). U6 snRNA, the parent molecule, is a highly conserved component of the spliceosome, essential for splicing introns from pre-mRNA in eukaryotic cells[1][3]. However, RNU6-631P itself is a pseudogene: it does not encode a functional snRNA and is not known to produce any active transcript or protein[4]. While some pseudogenes in the genome can regulate gene expression or act as decoys for microRNAs[2], there is no reported evidence in scientific literature or databases that RNU6-631P has any functional activity, clinical relevance, or therapeutic targeting potential. Its primary significance is as a genomic annotation, not as a target for drugs or clinical biomarkers[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 631, pseudogene (RNU6-631P).